PORTAGE BIOTECH HIGHLIGHTS INITIATION OF THE INVINCIBLE TRIAL, A PHASE 2 EARLY STAGE BREAST CANCER STUDY FROM INTENSITY THERAPEUTICS Press ReleaseBy Portage Biotech, IncMarch 25, 2021...
PORTAGE BIOTECH DIVESTS PORTAGE PHARMACEUTICALS LIMITED TO JUVENESCENCE LTD Press ReleaseBy Portage Biotech, IncMarch 4, 2021...
PORTAGE ANNOUNCES FILING OF THIRD QUARTER FINANCIAL STATEMENTS Press ReleaseBy Portage Biotech, IncMarch 2, 2021...
PORTAGE BIOTECH PROVIDES RESEARCH AND DEVELOPMENT UPDATE AND ANNOUNCES NASDAQ LISTING APPROVAL Press ReleaseBy Portage Biotech, IncFebruary 11, 2021...
PORTAGE ANNOUNCES FILING OF Q1 INTERIM FINANCIAL STATEMENTS; CORRECTION TO SALVARX LOAN NOTE SETTLEMENT ANNOUNCEMENT Press ReleaseBy Portage Biotech, IncOctober 16, 2020...
PORTAGE ISSUES COMMON SHARES AND WARRANTS IN SETTLEMENT OF SALVARX LOAN NOTE OBLIGATIONS Press ReleaseBy Portage Biotech, IncOctober 13, 2020...
PORTAGE ANNOUNCES RELIANCE ON TEMPORARY REGULATORY RELIEF FOR FILING ANNUAL FINANCIAL STATEMENTS Press ReleaseBy Portage Biotech, IncJuly 28, 2020...
PORTAGE ANNOUNCES RESULTS OF ANNUAL MEETING; PRIVATE PLACEMENT UPDATE; CORPORATE UPDATE Press ReleaseBy Portage Biotech, IncJune 26, 2020...
PORTAGE RAISES MORE THAN US$6.7 MILLION THROUGH NON-BROKERED PRIVATE PLACEMENT; TEMPORARY SYMBOL CHANGE ON OTC MARKETS Press ReleaseBy Portage Biotech, IncJune 16, 2020...